
Anheuser-Busch InBev is set to report its Q1 2026 earnings on May 5, with analysts forecasting revenue of $14.69 billion, a 7.7% increase year-over-year, and earnings per share of $0.90, marking an 11.1% growth. This optimistic outlook is driven by strong sales of premium brands like Corona and Michelob Ultra and a recent 2.3% upward revision in EPS estimates. However, the company faces challenges including lower sales in China, currency fluctuations, and rising marketing costs, which could impact profit margins. Investors will watch closely to see how these factors affect the company's financial performance.